DRZID
MRK icon

DePrince Race & Zollo Inc (DRZ)’s Merck MRK Stock Holding History

DePrince Race & Zollo Inc (DRZ)’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-240,734
Closed -$20.2M – 196
2025
Q3 		$20.2M Sell
240,734
-4,885
-2% -$402K 0.41% 109
2025
Q2 		$19.4M Sell
245,619
-78,208
-24% -$6.22M 0.4% 99
2025
Q1 		$29.1M Sell
323,827
-1,957
-0.6% -$183K 0.6% 74
2024
Q4 		$32.4M Buy
325,784
+28,047
+9% +$2.89M 0.64% 67
2024
Q3 		$33.8M Buy
297,737
+8,793
+3% +$1.04M 0.65% 73
2024
Q2 		$35.8M Sell
288,944
-3,604
-1% -$464K 0.8% 49
2024
Q1 		$38.6M Sell
292,548
-3,112
-1% -$384K 0.83% 43
2023
Q4 		$32.2M Buy
295,660
+26,366
+10% +$2.74M 0.73% 58
2023
Q3 		$27.7M Buy
269,294
+8,041
+3% +$867K 0.67% 63
2023
Q2 		$30.1M Sell
261,253
-35,754
-12% -$4.06M 0.69% 51
2023
Q1 		$31.6M Sell
297,007
-35,467
-11% -$3.83M 0.73% 52
2022
Q4 		$36.9M Sell
332,474
-15,836
-5% -$1.62M 0.85% 31
2022
Q3 		$30M Sell
348,310
-1,607
-0.5% -$143K 0.77% 51
2022
Q2 		$31.9M Sell
349,917
-122,661
-26% -$10.9M 0.74% 59
2022
Q1 		$38.8M Buy
472,578
+33,381
+8% +$2.63M 0.75% 50
2021
Q4 		$33.7M Buy
439,197
+40,577
+10% +$3.23M 0.86% 36
2021
Q3 		$29.9M Sell
398,620
-6,976
-2% -$531K 0.8% 37
2021
Q2 		$31.5M Sell
405,596
-388
-0.1% -$28.9K 0.8% 31
2021
Q1 		$29.9M Buy
405,984
+138,368
+52% +$10.2M 0.8% 29
2020
Q4 		$20.9M Buy
267,616
+59,978
+29% +$4.59M 0.66% 54
2020
Q3 		$16.4M Buy
207,638
+999
+0.5% +$78.2K 0.62% 64
2020
Q2 		$15.2M Sell
206,639
-18,310
-8% -$1.38M 0.59% 71
2020
Q1 		$16.5M Buy
224,949
+20,850
+10% +$1.64M 0.76% 47
2019
Q4 		$17.7M Sell
204,099
-18,541
-8% -$1.52M 0.54% 90
2019
Q3 		$17.9M Sell
222,640
-20,494
-8% -$1.64M 0.52% 102
2019
Q2 		$19.5M Sell
243,134
-70,924
-23% -$5.43M 0.54% 88
2019
Q1 		$24.9M Sell
314,058
-102,263
-25% -$7.65M 0.68% 49
2018
Q4 		$30.4M Sell
416,321
-194,774
-32% -$13.7M 0.88% 22
2018
Q3 		$41.4M Sell
611,095
-102,343
-14% -$6.52M 0.93% 24
2018
Q2 		$41.3M Sell
713,438
-29,826
-4% -$1.68M 0.96% 24
2018
Q1 		$38.6M Buy
743,264
+25,844
+4% +$1.4M 0.91% 23
2017
Q4 		$38.5M Buy
717,420
+33,532
+5% +$1.86M 0.86% 27
2017
Q3 		$41.8M Sell
683,888
-194,513
-22% -$11.8M 0.94% 20
2017
Q2 		$53.7M Buy
878,401
+5,885
+0.7% +$358K 1.1% 9
2017
Q1 		$52.9M Sell
872,516
-77,844
-8% -$4.72M 1.09% 9
2016
Q4 		$53.4M Buy
950,360
+74,936
+9% +$4.39M 1.04% 14
2016
Q3 		$52.1M Sell
875,424
-138,591
-14% -$8.1M 1.1% 14
2016
Q2 		$55.7M Sell
1,014,015
-26,942
-3% -$1.43M 1.13% 11
2016
Q1 		$52.6M Sell
1,040,957
-191,189
-16% -$9.36M 1.06% 16
2015
Q4 		$62.1M Buy
+1,232,146
New +$62.1M 1.15% 15
2014
Q1 		– Sell
-1,054,676
Closed -$50.4M – 320
2013
Q4 		$50.4M Buy
+1,054,676
New +$48.2M 0.64% 54

Other funds holding MRK

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

DePrince Race & Zollo Inc (DRZ)'s MRK Position: Q4 2025 in Review

DePrince Race & Zollo Inc (DRZ) sold out of Merck (MRK) in Q4 2025, closing a stake of 240,734 shares — an estimated $20.2M sold.

DePrince Race & Zollo Inc (DRZ) first reported a position in MRK in Q4 2013 and held it in 41 quarters. The position peaked at $62.1M in Q4 2015. 3,656 funds tracked by Wall St. Rank hold MRK as of Q4 2025.

  • DePrince Race & Zollo Inc (DRZ) reported no remaining Merck position as of Q4 2025 after selling out during the quarter.
  • DePrince Race & Zollo Inc (DRZ) sold 240,734 Merck shares in Q4 2025, an estimated $20.2M.
  • DePrince Race & Zollo Inc (DRZ) first reported a position in Merck in Q4 2013 and held it in 41 quarters.
  • DePrince Race & Zollo Inc (DRZ)'s Merck position peaked at $62.1M in Q4 2015.
  • 3,656 funds tracked by Wall St. Rank held Merck as of Q4 2025.

Based on DePrince Race & Zollo Inc (DRZ)'s 13F filing for Q4 2025, filed 23 Jan 2026.